reference/25541120

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25541120

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	55, 755.e1
issn	0161-6420
issueIdentifier	4
pageRange	747-55, 755.e1
publicationName	Ophthalmology
startingPage	747
bibliographicCitation	Kaiser PK; Registry of Visudyne AMD Therapy Writing Committee, Boyer DS, Garcia R, Hao Y, Hughes MS, Jabbour NM, Kaiser PK, Mieler W, Slakter JS, Samuel M, Tolentino MJ, Roth D, Sheidow T, Strong HA. Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Ophthalmology. 2009 Apr;116(4):747–55, 755.e1. doi: 10.1016/j.ophtha.2008.12.057. PMID: 19243834.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73269efb77640cf07e4dd3e406cc8e29 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca5c1d6bdf897f0cc3e1fe5cd83be868 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80644723e9619b61784ae976e006d4a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afa8b4d819f9c0c54167be51f07e73cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6caff0b7711242028e3797ef19b0aed2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66deda602e1cb97418bdda8ad069712a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e966437e216ca2826c063368c6233cda http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc6bd35fa81a5d69f1c48118b4462a2f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2abc2637a83f8908fdf3462fa167189 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83179efad747c2d6db92eebbe6f592f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77eabfc53015dd725ac1fb9abe1befeb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f01e12abb16ff3ecc2bb4b471eec41d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72d34a8bcdbd7a8d39934da39c3acd4c
date	200904
identifier	https://doi.org/10.1016/j.ophtha.2008.12.057 https://pubmed.ncbi.nlm.nih.gov/19243834
isPartOf	https://portal.issn.org/resource/ISSN/0161-6420 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6266
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Verteporfin Photodynamic Therapy Combined With Intravitreal Bevacizumab for Neovascular Age-Related Macular Degeneration
discusses	http://id.nlm.nih.gov/mesh/M0356369 http://id.nlm.nih.gov/mesh/M0258373 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0328153 http://id.nlm.nih.gov/mesh/M0017336 http://id.nlm.nih.gov/mesh/M0026299 http://id.nlm.nih.gov/mesh/M0443627 http://id.nlm.nih.gov/mesh/M0556300
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D017319Q000627 http://id.nlm.nih.gov/mesh/D020256Q000188 http://id.nlm.nih.gov/mesh/D011166Q000627 http://id.nlm.nih.gov/mesh/D010778 http://id.nlm.nih.gov/mesh/D020533Q000627 http://id.nlm.nih.gov/mesh/D008268Q000188 http://id.nlm.nih.gov/mesh/D000911Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D014822 http://id.nlm.nih.gov/mesh/D020256Q000503 http://id.nlm.nih.gov/mesh/D042461Q000037 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D014792Q000502 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D000077362 http://id.nlm.nih.gov/mesh/D007267 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D020256Q000209 http://id.nlm.nih.gov/mesh/D000068258 http://id.nlm.nih.gov/mesh/D008268Q000150 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008268Q000503
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10521 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7671 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8397

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136090971

Total number of triples: 71.